1
|
Abdelhamid NM, Chen YC, Wang YC, Cheng CH, Wu TJ, Lee CF, Wu TH, Chou HS, Chan KM, Lee WC, Soong RS. Pre-Transplantation Immune Cell Distribution and Early Post-Transplant Fungal Infection Are the Main Risk Factors of Liver Transplantation Recipients in Lower Model of End-Stage Liver Disease. Transplant Proc 2017; 49:92-97. [PMID: 28104167 DOI: 10.1016/j.transproceed.2016.11.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
BACKGROUND The prognosis of patients after liver transplantation (LTx) with high Model of End-Stage Liver Disease (MELD) score (>30) is predicted, but patients with lower MELD scores (<30) have no conclusive studies of pre- and post-transplant risk factors that influence the long-term outcome. METHODS This retrospective study reviewed 268 recipients with MELD score <30, from 2008 to 2013 in our institution, for evaluation of pre-transplant risk factors including patients' clinical background data, pre-transplant lymphocyte subpopulation, and early post-transplant infection complication as predictors for long-term survival after LTx. RESULTS The post-transplant patients' survival estimates were 90.7%, 85.1%, and 83.6% at 1, 3, and 5 years, respectively. In multivariate analysis, age >55years, presence of ascites, cluster of differentiation (CD)3 < 93.2 (count/μL), CD4/CD8 <2.4, fungal infection, and more than one site of fungal colonization significantly influenced survival (P = .0003, P = .002, P = .04, P = .004, P < .0001, and P > .0001, respectively). We also noticed that these five factors accumulatively influence the long-term survival rate; this means that in the presence of any two risk factors, the 5-year survival can still be 88.4%, whereas in the presence of any three risk factors, the survival rate dropped to only 57.1%. CONCLUSIONS Older patients in the presence of pre-transplant low immune cell number and ascites in association with post-transplant fungal infection are the independent risk factors in MELD scores <30 LTx groups for long-term survival. Patients in these groups with any of the three factors had inferior long-term survival results.
Collapse
Affiliation(s)
- N M Abdelhamid
- General Surgery Department, Al-Azhar Faculty of Medicine, Cairo, Egypt; Liver Transplantation Department, Chang Gung Memorial Hospital, Linko, Taiwan
| | - Y-C Chen
- General Surgery Department, Chang Gung Memorial Hospital, Keelung, Taiwan; Liver Transplantation Department, Chang Gung Memorial Hospital, Linko, Taiwan
| | - Y-C Wang
- Liver Transplantation Department, Chang Gung Memorial Hospital, Linko, Taiwan
| | - C-H Cheng
- Liver Transplantation Department, Chang Gung Memorial Hospital, Linko, Taiwan
| | - T-J Wu
- Liver Transplantation Department, Chang Gung Memorial Hospital, Linko, Taiwan
| | - C-F Lee
- Liver Transplantation Department, Chang Gung Memorial Hospital, Linko, Taiwan
| | - T-H Wu
- Liver Transplantation Department, Chang Gung Memorial Hospital, Linko, Taiwan
| | - H-S Chou
- Liver Transplantation Department, Chang Gung Memorial Hospital, Linko, Taiwan
| | - K-M Chan
- Liver Transplantation Department, Chang Gung Memorial Hospital, Linko, Taiwan
| | - W-C Lee
- Liver Transplantation Department, Chang Gung Memorial Hospital, Linko, Taiwan; Chang Gung University, Taoyuan, Taiwan
| | - R-S Soong
- General Surgery Department, Chang Gung Memorial Hospital, Keelung, Taiwan; Liver Transplantation Department, Chang Gung Memorial Hospital, Linko, Taiwan; Chang Gung University, Taoyuan, Taiwan.
| |
Collapse
|
2
|
Uemoto S, Ozawa K, Kaido T, Mori A, Fujimoto Y. Advantage of tacrolimus/mycophenolate mofetil regimen for cytotoxic T cell-mediated defence and its inhibition by additive steroid administration in high-risk liver transplant recipients. Clin Exp Immunol 2015; 184:126-36. [PMID: 26560892 DOI: 10.1111/cei.12740] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 11/03/2015] [Indexed: 11/28/2022] Open
Abstract
Our previous work revealed that the recipients with the highest pre-existing numbers of CD8(+) effector T cells (TE ) [hyperparathyroidism (HPT)E recipients] occupied approximately 30% of adult transplant recipients performed in our hospital. HPTE recipients demonstrated very poor clinical outcome compared with the remaining 70% of recipients with the lowest pre-existing TE (LPTE recipient). This study aimed to clarify the best combined immunosuppressive regimen related to function of cytotoxic T lymphocytes (CTLs) for HPTE recipients. Eighty-one HPTE recipients were classified into three types, according to the immunosuppressive regimens: type 1, tacrolimus (Tac)/glucocorticoid (GC); type 2, Tac/mycophenolate mofetil (MMF)/GC; and type 3, Tac/MMF. Frequencies of severe infection, rejection and hospital death were the highest in types 1 and 2, whereas the lowest occurred in type 3. The survival rate in type 3 was the highest (100%) during follow-up until post-operative day 2000. Regarding the immunological mechanism, in type 1 TE perforin and interferon (IFN)-γ were generated through the self-renewal of CD8(+) central memory T cells (TCM ), but decreased in the early post-transplant period due to marked down-regulation of interleukin (IL)-12 receptor beta-1 of TCM. In type 2, the self-renewal TCM did not develop, and the effector function could not be increased. In type 3, in contrast, the effectors and cytotoxicity were correlated inversely with IL-12Rβ1(+) TCM levels, and increased at the highest level around the pre-transplant levels of IL-12Rβ1(+) TCM . However, the immunological advantage of Tac/MMF therapy was inhibited strongly by additive steroid administration.
Collapse
Affiliation(s)
- S Uemoto
- Department of Surgery, Graduate School of Medicine, Kyoto University, Japan
| | - K Ozawa
- Hepatic Disease Research Institute, Kyoto, Japan
| | - T Kaido
- Department of Surgery, Graduate School of Medicine, Kyoto University, Japan
| | - A Mori
- Department of Surgery, Graduate School of Medicine, Kyoto University, Japan
| | - Y Fujimoto
- Department of Surgery, Graduate School of Medicine, Kyoto University, Japan
| |
Collapse
|
3
|
Uemoto S, Ozawa K, Kaido T, Mori A, Fujimoto Y, Ogawa K. Early coupled up-regulation of interleukin-12 receptor beta-1 in CD8+ central memory and effector T cells for better clinical outcomes in liver transplant recipients. Clin Exp Immunol 2015; 181:373-84. [PMID: 25603847 DOI: 10.1111/cei.12588] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/27/2014] [Revised: 01/09/2015] [Accepted: 01/09/2015] [Indexed: 11/29/2022] Open
Abstract
This study aimed to investigate the role of initial priming of interleukin (IL)-12 receptor beta-1 in CD8(+) central memory T cells (initial IL-12RTCM priming) and CCR7-negative subsets (CNS) in effector cell expansion and clinical outcome after living donor liver transplantation (LDLT). One hundred and six patients who underwent LDLT were classified into the following three groups according to hierarchical clustering of CD8(+) CD45 isoforms before LDLT: I, naive-dominant; II, effector memory-dominant; and III, effector-dominant. The pre-existing CD8(+) effector cells (TE ) and activated immune status increased progressively from group I to group II to group III. Groups I, II and III received tacrolimus (Tac)/glucocorticoid (GC) regimens. Eighteen group III recipients received Tac/mycophenolate mofetil (MMF) and were defined as group IV. Initial IL-12RTCM priming was slightly, moderately and markedly decreased in droups I, II, and III, respectively. Initial priming of IL-12Rβ1 in CNS was decreased markedly in the three groups with marked decreases of TE , perforin and interferon (IFN)-γ; all parameters were restored by up-regulation of IL-12Rβ1(+) TCM through the self-renewal of TCM . The lag time required until coupled up-regulation of IL-12Rβ1 of TCM and CNS to above baseline was 12, 20 and 32 days in groups I, II and III, respectively. Inferior clinical outcomes were associated with increasing lag time. In contrast, the initial priming of IL-12Rβ1 in TCM and CNS remained above baseline in group IV due to MMF-mediated increase of IL-12Rβ1. Early coupled up-regulation of TCM and CNS leads to efficient TE differentiation and optimal clinical outcomes.
Collapse
Affiliation(s)
- S Uemoto
- Department of Surgery, Graduate School of Medicine, Kyoto University, Japan
| | - K Ozawa
- Hepatic Disease Research Institute, Kyoto, Japan
| | - T Kaido
- Department of Surgery, Graduate School of Medicine, Kyoto University, Japan
| | - A Mori
- Department of Surgery, Graduate School of Medicine, Kyoto University, Japan
| | - Y Fujimoto
- Department of Surgery, Graduate School of Medicine, Kyoto University, Japan
| | - K Ogawa
- Department of Surgery, Graduate School of Medicine, Kyoto University, Japan
| |
Collapse
|
4
|
Takada Y, Ozawa K, Egawa H, Teramukai S, Mori A, Kaido T, Kasahara M, Ogawa K, Ono M, Sato H, Tanaka K, Uemoto S. Initial burst of viremia related to CD8 effector memory T cells after living donor liver transplantation in hepatitis C virus-infected recipients. Transl Res 2010; 156:68-79. [PMID: 20627191 DOI: 10.1016/j.trsl.2010.06.002] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/18/2009] [Revised: 06/06/2010] [Accepted: 06/08/2010] [Indexed: 10/19/2022]
Abstract
The post-transplant immune responses, viremia, and allograft histology after living donor liver transplantation were studied in 39 hepatitis C virus (HCV)-infected recipients. The recipients were classified into the following groups according to a hierarchical clustering of their preoperative CD8CD45 T-cell isoforms: group I, naive-dominant; group II, effector memory-dominant; and group III, effector-dominant. Plasma HCV-RNA rapidly increased and then peaked as an initial burst around postoperative day (POD) 25 in group I, on POD 40 in group II, and on POD 55 in group III. The initial burst of viremia was suppressed by the high expression of CD8+CD28-CD27- subsets. The progression of fibrosis > or =F2 was significantly more frequent for those patients with the highest viremia levels. Moreover, the initial T-cell immune response became less important throughout time, and new immune responses emerged after 2 months that modified the host-virus interaction. It is suggested that the interferon (IFN)-alpha/ribavirin therapy starting 2 months may be an effective option and now is undertaken.
Collapse
Affiliation(s)
- Yasutsugu Takada
- Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
5
|
Egawa H, Ozawa K, Takada Y, Teramukai S, Mori A, Ogawa K, Kaido T, Fujimoto Y, Kawaguchi Y, Hatano E, Sato H, Ono M, Takai K, Tanaka K, Uemoto S. Coupled regulation of interleukin-12 receptor beta-1 of CD8+ central memory and CCR7-negative memory T cells in an early alloimmunity in liver transplant recipients. Clin Exp Immunol 2010; 160:420-30. [PMID: 20345976 DOI: 10.1111/j.1365-2249.2010.04117.x] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023] Open
Abstract
This study investigated how CD8(+) T cell subsets respond to allo- and infectious immunity after living donor liver transplantation (LDLT). Early alloimmunity: 56 recipients were classified into three types according to the post-transplant course; type I demonstrated uneventful post-transplant course, type II developed severe sepsis leading to multiple organ dysfunction syndrome or retransplantation and type III with acute rejection. In 23 type I recipients, the interleukin (IL)-12 receptor beta-1 (R beta 1)(+) cells of central memory T cells (Il-12R beta 1(+) T(CM)) were increased above the pretransplant level. In 16 type II recipients, IL-12R beta 1(+) T(CM) was decreased markedly below the pretransplant level on postoperative day (POD) 5. In 17 type III recipients, IL-12R beta 1(+) T(CM) was decreased for a more prolonged period until POD 10. Along with down-regulation of IL-12R beta 1(+) T(CM), the IL-12R beta 1(+) cells of CCR7-negative subsets (CNS) as well as perforin, interferon (IFN)-gamma and tumour necrosis factor (TNF)-alpha decreased gradually, resulting in the down-regulation of effectors and cytotoxicity. The down-regulation of IL-12R beta 1(+) T(CM) was suggested to be due to the recruitment of alloantigen-primed T cells into the graft, and then their entry into the secondary lymphoid organ, resulting in graft destruction. Infectious immunity: immunocompetent memory T cells with the capacity to enhance effectors and cytotoxicity were generated in response to post-transplant infection along with both up-regulation of the IL-12R beta 1(+) T(CM) and an increase in the CNS showing the highest level of IL-12R beta 1(+) cells. In conclusion, this work demonstrated that the IL-12R beta 1(+) cells of T(CM) and CNS are regulated in a tightly coupled manner and that expression levels of IL-12R beta 1(+) T(CM) play a crucial role in controlling allo- and infectious immunity.
Collapse
Affiliation(s)
- H Egawa
- Department of Surgery, Graduate School of Medicine, Kyoto University, Tokyo, Japan
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
6
|
Egawa H, Ozawa K, Takada Y, Teramukai S, Mori A, Kasahara M, Ogawa K, Ogura Y, Oike F, Kaido T, Ono M, Sato H, Takai K, Uemoto S. Impact of preexisting circulating effector T cells on the outcome of ABO-incompatible adult LDLT. Dig Dis Sci 2009; 54:2253-63. [PMID: 19082716 PMCID: PMC7102009 DOI: 10.1007/s10620-008-0618-y] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/07/2008] [Accepted: 11/03/2008] [Indexed: 12/09/2022]
Abstract
Our aim was to clarify the significance of phenotype of circulating CD8 T(+) cells on the outcome of ABO-incompatible (ABO-I) living donor liver transplantation (LDLT). Twenty-six recipients undergoing ABO-I LDLT and 92 undergoing ABO-compatible (ABO-C) LDLT were classified into three groups according to preoperative proportion of CD8 T(+) cells: naive-dominant (group I), effector memory-dominant (group II), and effector-dominant (group III) recipients. The clinical courses were analyzed. The results showed that in ABO-C groups I and II and in ABO-I group I, effector cells remained above the pretransplant levels after tacrolimus administration. However, in ABO-C group III and ABO-I groups II and III, effector cells were down-regulated for a prolonged period, along with markedly decreased perforin expression and frequent life-threatening complications. ABO-I group II and group III recipients had higher infection rates. It was concluded that recipients with preexisting high effector CD8 T(+) cells are unfavorable candidates for ABO-I LDLT.
Collapse
Affiliation(s)
- Hiroto Egawa
- Department of Surgery, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho Shogoin, Sakyo-ku, Kyoto, 606-8501 Japan
| | - Kazue Ozawa
- Hepatic Disease Research Institute, Kyoto, 605-0981 Japan
| | - Yasutsugu Takada
- Department of Surgery, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho Shogoin, Sakyo-ku, Kyoto, 606-8501 Japan
| | - Satoshi Teramukai
- Division of Clinical Trial Design and Management, Translational Research Center, Kyoto University Hospital, Kyoto, 606-8501 Japan
| | - Akira Mori
- Department of Surgery, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho Shogoin, Sakyo-ku, Kyoto, 606-8501 Japan
| | - Mureo Kasahara
- Department of Surgery, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho Shogoin, Sakyo-ku, Kyoto, 606-8501 Japan
| | - Kohei Ogawa
- Department of Surgery, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho Shogoin, Sakyo-ku, Kyoto, 606-8501 Japan
| | - Yasuhiro Ogura
- Department of Surgery, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho Shogoin, Sakyo-ku, Kyoto, 606-8501 Japan
| | - Fumitaka Oike
- Department of Surgery, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho Shogoin, Sakyo-ku, Kyoto, 606-8501 Japan
| | - Toshimi Kaido
- Department of Surgery, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho Shogoin, Sakyo-ku, Kyoto, 606-8501 Japan
| | - Masako Ono
- Hepatic Disease Research Institute, Kyoto, 605-0981 Japan
| | - Hiroshi Sato
- Division of Bioscience, Shiga University of Medical Science, Shiga, 520-2192 Japan
| | | | - Shinji Uemoto
- Department of Surgery, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho Shogoin, Sakyo-ku, Kyoto, 606-8501 Japan
| |
Collapse
|